Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BASi Expands Discovery Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

BASi Expands Discovery Services

BASi (Bioanalytical Systems, Inc.) has added the ability to work with large animals through its Culex Automated In Vivo Discovery Services.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BASi (Bioanalytical Systems, Inc.) has added the ability to work with large animals through its Culex Automated In Vivo Discovery Services. According to the company, the process offers extensive, faster and more meaningful results to help develop new drugs, while easing the stress on animals. Additionally, the company has added non-clinical scientist Brad Gien to its Culex services team.

The Culex Automated In Vivo Sampling Services offer investigators a way to increase the amount and type of data gathered in drug discovery experiments with small and now large animal models. By offering both, clients will have a broader range of options in study design. Additionally, Culex allows programmed sampling of blood and other body fluids without human intervention, at any time, or continuously for 24 hours or more. This approach reduces animal usage and helps to provide stronger data.

“One major benefit of automated sampling is reduced stress in the subject,” said Craig Bruntlett, senior vice president of instrumentation. “Stress can create a significant impact on the physiological parameters and can make data difficult to interpret. Reducing stress for the animal can lead to cleaner, more meaningful data.”

Mr. Gien joins the company with 10 years of experience in biomedical research, extensive rodent surgery capability and familiarity with the automated Culex system. “His experience and surgical skills will expand the capability of the BASi PK/PD laboratory in Mt. Vernon, IN,” said director of toxicology, David Hopper.


Click here to learn more about BASi

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics